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Loss of chromosome 7 (27) or deletion of the long arm (7q2)
are recurring chromosome abnormalities in myeloid leuke-
mias. The association of 27/7q2 with myeloid leukemia
suggests that these regions contain novel tumor suppressor
gene(s), whose loss of function contribute to leukemic
transformation or tumor progression. Based on chromo-
some banding analysis, two critical regions have been identi-
fied, one in band q22 and another in bands q32-q35. Pres-
ently there are no data available on the molecular delineation
of the distal critical region. In this study we analyzed bone
marrow and blood samples from 13 patients with myeloid
leukemia (de novo myelodysplastic syndrome [MDS] , n 5 3;
de novo acute myeloid leukemia [AML], n 5 9; therapy-
related (t-) AML, n 5 1) which, on chromosome banding
analysis, exhibited deletions (n 5 12) or in one case a
balanced translocation involving bands 7q31-qter using fluo-
rescence in situ hybridization (FISH). As probes we used
representative clones from a contig map of yeast artificial
chromosome (YAC) clones that spans chromosome bands
7q31.1-qter. In the 12 cases with loss of 7q material, we
identified a commonly deleted region of approximately 4 to 5
megabasepairs in size encompassing the distal part of 7q35
and the proximal part of 7q36. Furthermore, the breakpoint
of the reciprocal translocation from the patient with t-AML
was localized to a 1,300-kb sized YAC clone that maps to the
proximal boundary of the commonly deleted region. Interest-
ingly, in this case both homologs of chromosome 7 were
affected: one was lost (27) and the second exhibited the
t(7q35). The identification and delineation of translocation
and deletion breakpoints provides the first step toward the
identification of the gene(s) involved in the pathogenesis of
7q35-q36 aberrations in myeloid disorders.
r 1998 by The American Society of Hematology.
CHROMOSOME 7 has been a focus of attention as a siteharboring tumor suppressor genes since cytogenetic
studies have shown deletions of its long arm (7q) in various
tumor types.1,2 In myeloid disorders, loss of chromosome 7
(27) or deletion of the long arm (7q2) are among the most
common recurrent chromosome abnormalities. These aberra-
tions are associated with myelodysplastic syndrome (MDS) and
acute myeloid leukemia (AML), in particular with therapy-
related MDS/AML (t-MDS/t-AML) following therapy with
alkylating agents or secondary MDS/AML after occupational
exposure to chemical mutagens.3-5 Furthermore, 27/7q2 occur
in MDS and AML that develop in patients with constitutional
disorders (eg, Fanconi’s anemia, Kostmann’s syndrome, neuro-
fibromatosis type 1, familial monosomy 7).6 Clinically, myeloid
leukemias exhibiting 27/7q2 have been associated with high
susceptibility to infections, poor response to chemotherapy, and
short survival times.3,7
By chromosome banding analysis two critical regions on the
long arm of chromosome 7 have been identified, one in band
7q22 and another in bands 7q32-q35.5,8-11 The recurrent loss of
genetic material suggests that these regions contain as yet
unidentified tumor suppressor gene(s) which contribute to
myeloid leukemogenesis. The molecular delineation of the
proximal critical region in 7q22 has been the focus of several
investigations.11-16 Using fluorescence in situ hybridization
(FISH) and loss of heterozygosity (LOH) studies, distinct
critical regions in bands 7q22-q31.1 have been identified which
are shown to be commonly deleted or to contain translocation/
inversion breakpoints in myeloid disorders.11-16
The distal critical region in 7q has so far only been delineated
by chromosome banding analysis. In a study by Rodrigues
Pereira Velloso et al10 of 54 patients with MDS and AML, bands
7q22 and 7q32 were most commonly deleted in the proximal
and distal critical region, respectively. Le Beau et al11 reported
on 16 cases with de novo MDS/AML and t-MDS/t-AML
exhibiting deletions involving the distal part of 7q. All deletions
were interstitial with the proximal and the majority of distal
breakpoints localized to 7q31 or 7q32 and 7q36, respectively.
The commonly deleted segment in this study was delineated to
bands 7q32-q33.
In the present study, we analyzed samples from 13 patients
with myeloid leukemia exhibiting deletions or a translocation
affecting bands 7q31-qter by FISH. As probes we selected
representative yeast artificial chromosome (YAC) clones from a
physical map encompassing bands 7q31-qter.17-19 Because
overlapping YACs were used, it was possible to systematically
delineate the extent of the deletions and to locate the breakpoint
of one reciprocal translocation at the molecular level.
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MATERIALS AND METHODS
Patients. Bone marrow and/or blood samples from 13 patients with
myeloid disorders (de novo MDS, n 5 3 [nos. 1-3]; de novo AML, n 5
9 [nos. 4-12]; t-AML, n 5 1 [no. 13]) were studied which, on
chromosome banding analysis and/or FISH, exhibited deletions or
translocations of bands 7q31-qter (Table 1). Chromosome banding
analysis was performed using standard methods, and the karyotypes
were designated according to the International System for Cytogenetic
Nomenclature.20
DNA probes. For the metaphase and interphase FISH experiments,
we selected representative clones from a panel of YAC clones (Fig 1)
that were previously mapped to chromosome bands 7q31.1 to 7qter
(genes which are present on each YAC are given in parentheses)17-19,21:
HSC7E161 (PDS, PRKAR2B, DRA), HSC7E132, HSC7E589,
HSC7E222, HSC7E648, HSC7E1175 (ALDR1, BPGM, CALD1),
HSC7E116 (CHRM2), HSC7E190, HSC7E248 (CLCN1, NEDD2),
HSC7E630 (CLCN1, NEDD2), C_940_a_12 (NEDD2, TRCB, PRSS1,
KEL, PIP1, CLCN1), C_761_H_5 (TIM1), C_745_G_6, C_945_H_1,
HSC7E162, C_932_D_12, HSC7E124, HSC7E131, C_868_G_5,
C_880_B_7, HSC7E113, C_724_G_5 (RHEB), HSC7E802 (XRCC2),
HSC7E224, HSC7E769 (DPP6, HTR5A, APCR), and HSC7E526
(VIPR2). Clones HSC7E248 through HSC7E113 recognize a contigu-
ous genomic fragment in 7q35-q36. Detailed information on the YACs
is available at: http://www.genet.sickkids.on.ca/chromosome7/ and http://
www.cephb.fr/ceph-genethon-map.html.
To ensure that the distal 7q deletions did not contiguously involve the
proximal critical region in 7q22-q31, all cases were also hybridized
with YAC clones HSC7E481 (7q21.1-q21.3) and HSC7E506 (7q22).
We previously showed that YAC HSC7E506 recognizes a genomic
fragment that is contained in the proximal critical region.12
Human sequences from the YAC clones were generated by a
polymerase chain reaction (PCR) protocol using primers directed
against Alu-sequences.22 Amplification was performed in a 100-µL
reaction mixture containing approximately 160 ng YAC-DNA, 100
mmol/L of the four dNTPs (Boehringer Mannheim, Mannheim, Ger-
many), 10 µL PCR-buffer (Boehringer Mannheim), and 2.0 mmol/L
MgCl2 (Boehringer Mannheim). Three Alu-PCR reactions were per-
formed using either the primers CL1, CL2, or a combination of both
(0.5 µmol/L). The products of all three reactions were combined for use
in the FISH experiments. The Alu-PCR products were labeled by nick
translation with biotin-16-dUTP or digoxigenin-11-dUTP (Boehringer
Mannheim).
FISH. FISH was performed as described.23,24 The hybridization
mixture contained approximately 250 ng labeled Alu-PCR product, 10
µg Cot-1 DNA fraction (BRL/Life-Technologies, Gaithersburg, MD),
and 10 µg salmon sperm DNA (Sigma Deisenhofen, Germany).
Interphase cytogenetic analysis was performed for deletion mapping.
To monitor the hybridization efficiency we cohybridized with a YAC
clone from 7q that mapped outside the region of interest. By analogy to
our previous studies on deletion analyses, the cut-off level was defined
by the mean 1 3 SD of the frequency of control cells exhibiting only
one fluorescence signal.12,23 The cut-off levels were determined for five
representative YACs from the YAC map (range, 4.5% to 7.6%). Signal
numbers were enumerated in 200 to 300 nuclei. The breakpoint of the
balanced translocation t(3;7)(p13;q34 or q35) was additionally identi-
fied by metaphase FISH.
RESULTS
Chromosome banding analysis. As determined by chromo-
some banding analysis, 11 of the 13 cases had aberrations
involving bands 7q31-qter. The remaining two cases had
monosomy 7 (no. 4) and a deletion del(7)(q?22) (no. 8) within a
complex karyotype including unidentified marker chromo-
somes. The loss of 7q material resulted from terminal deletions
(cases 1, 6, 7, 8, and 10) and unbalanced translocations (cases 2,
3, 5, 9, 11, and 12). The commonly deleted segment was defined
as 7q35-qter (see Fig 2). Case 13 exhibited a balanced
translocation t(3;7) with a breakpoint in band 7q34 or q35.
Interestingly, this case also had monosomy 7. This patient had
received total body irradiation and high-dose cyclophospha-
mide followed by autologous bone marrow transplantation for
stage IV follicular lymphoma. Two years after transplantation
the patient developed t-MDS which rapidly progressed to
t-AML. Cytogenetic analysis of phytohemagglutinin (PHA)-
stimulated blood at the time of diagnosis of the t-AML showed a
normal karyotype. The karyotypes of the 13 leukemias are
given in Table 1.
Deletion and translocation mapping by FISH. The results
of the deletion/translocation mapping by FISH are given in
Fig 1. To delineate the commonly deleted segment in 7q31-qter
at the molecular level, we selected a panel of YACs distributed
along 7q31.1-qter, including a set of contiguously mapped
YACs in bands 7q35-q36. In the 12 MDS/AML cases exhibiting
7q deletions, unbalanced 7q translocations, or monosomy 7
within a complex karyotype, we identified a commonly deleted
region in bands 7q35-q36. In the case of t-AML with the t(3;7),
we localized the 7q breakpoint to a 1,300-kb sized genomic
segment in 7q35.
The commonly deleted segment in the 12 MDS/AML cases
extended from YAC HSC7E124 in the distal part of band 7q35
to YAC C_724_G_5 in the proximal part of band 7q36 (Fig 1).
This segment comprises approximately 4 to 5 megabasepairs
(Mb). The proximal boundary of this segment was defined by
cases 4 and 5. As illustrated in Fig 1, there is marked
heterogeneity of the proximal deletion breakpoints among the
cases: within bands 7q31.1-q35 the breakpoints were scattered
along a large region extending from the genomic segments
recognized by YAC HSC7E132 (case 3) to YAC HSC7E124
(cases 4 and 5). In case 12 the proximal deletion breakpoint was
located between YAC HSC7E161 (7q31.1) and YAC HSC7E506
Table 1. Karyotypes of the 13 Myeloid Leukemias
Case No. Karyotype
De novo MDS
1 46,XX,del(7)(q35)
47,XX,del(7)(q35),18
2 43-45,XX,add(7)(q33-36),inc
3 41-46,XX,add(7)(q32),inc
De novo AML
4 48,XX,27,inc
5 46,XY,der(7)t(7;13)(q32;q12)
6 45,XY,del(7)(q31),217
7 46,XY,del(7)(q3?4),217,1r
8 46,XY,del(7)(q?22),inc
46,XY,del(7)(q?22),27,1mar,inc
9 46,XY,der(7)t(1;7)(q11;q31)
10 46,XY,t(8;21)(q22;q22)
46,XY,del(7)(q32),t(8;21)(q22;q22)
11 47,XX,add(7)(q31),113
12 46,XX,add(7)(q3?1),t(15;17)(q22;q21)
t-AML
13* 45,X,2X,t(3;7)(p13;q34 or q35),27,213,1mar
*46,XX in PHA-stimulated blood.
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(7q22). For case 6 we could not determine the exact proximal
deletion breakpoint because of the limited amount of material
available. The distal boundary of the commonly deleted seg-
ment was defined by cases 4 and 6. In the remaining cases the
deletions extended distal to the genomic region identified by
YAC C_724_G_5 in band 7q36. In 5 (nos. 2, 5, 9, 11, and 12) of
the 12 deletion cases, there was loss of the telomeric sequences
(detected by YAC HSC7E526). Interestingly, case 6 had a
noncontiguous deletion involving a genomic fragment in the
proximal critical region in 7q22-q31 (identified by YAC
HSC7E506) and in the distal critical region 7q35-q36 (identi-
fied by YACs HSC7E124 to C_724_G_5). In contrast to the
interpretation of chromosome banding analysis, bands 7q32-
q35 were retained. None of the other cases had deletion within
the proximal critical region in 7q22-q31.
The breakpoint of the t(3;7)(p13;q34 or q35) (case 13) was
mapped to a 1,300-kb genomic segment encompassed by YAC
C_945_H_1 in band 7q35. This genomic fragment is located
near the proximal boundary of the commonly deleted region.
Based on the available physical map from this region, the
distance between the translocation breakpoint and the com-
monly deleted region is estimated to be in the range of 2 to 3
Mb. There was no deletion detectable in the homolog involved
in the translocation. FISH using YAC C_945_H_1 and a
centromere 7 specific probe (Oncor Inc, Gaithersburg, MD)
confirmed the results from chromosome banding analysis that
the tumor also had monosomy 7. FISH using the centromere 7
probe and YAC C_945_H_1 on PHA-stimulated blood from this
patient that was obtained at the time of the development of
t-AML showed two hybridization signals for both probes,
indicating that the translocation t(3;7) was not constitutional but
somatically acquired. These data are supported by FISH with
the same probes performed on mononuclear cells from the
autologous bone marrow graft obtained 2 years before the
development of t-AML. Hybridization again showed two
fluorescence signals for the centromere 7 probe and YAC
C_945_H_1.
DISCUSSION
Using FISH with YAC clones of defined physical position,
we identified a commonly deleted genomic segment in 12 cases
of myeloid leukemias exhibiting deletions of the distal part of
7q. Furthermore, we mapped the translocation breakpoint of a
reciprocal translocation to a 1,300-kb sized genomic segment
that is located at the proximal boundary of the commonly
deleted region.
In the 12 MDS/AML cases with loss of 7q material we
delineated a commonly deleted genomic segment of approxi-
mately 4 to 5 Mb in size encompassing the terminal part of band
7q35 and the proximal part of band 7q36. The proximal
breakpoints in the deletion cases scattered along a large region
extending from bands 7q31.1 to 7q35. The distal boundary of all
Fig 1. Mapping of deletions and a translocation involving chromosome bands 7q31-qter in 13 myeloid leukemias by FISH. HSC7E-YACs are
from the chromosome 7–specific YAC library17 and the C_row_plate_ column YACs are from the CEPH-Ge´ne´thon collection.21 Clones HSC7E248 to
HSC7E113 recognize a contiguous genomic fragment in chromosome bands 7q35-q36. del, deletion (only one fluorescence signal); t,
translocation breakpoint; di, disomy (two fluorescence signals indicating retention of both alleles); empty boxes, not done; light gray boxes,
extent of the deletion; dark gray boxes, commonly deleted segment.
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the deletions extended into band 7q36, with 5 of the 12 cases
involving the telomeric sequences detected with YAC
HSC7E526. With respect to the chromosomal location of the
critical region, our data are at variance to those obtained by
chromosome banding analysis. In two recent chromosome
banding studies, the commonly deleted region was assigned to
bands 7q32-q33, whereas in our study the critical segment was
delineated to a more distal region in 7q35-q36.10,11 FISH using
probes from a defined physical map is the more sensitive
technique for the delineation and chromosomal mapping of a
critical segment, particularly in a region where chromosomal
assignment of breakpoints may be difficult. In one of our cases
(no. 6) we were able to identify a noncontiguous deletion by
FISH involving the proximal (7q22-q31) and the distal (7q35-
q36) critical region. Such high resolution cannot be achieved by
the chromosome banding techniques.
In one case of t-AML, the translocation breakpoint of a
reciprocal translocation t(3;7)(p13;q34 or q35) was identified
and localized to a 1,300-kb sized genomic segment that is
localized near the proximal boundary of the commonly deleted
region. Interestingly, in this case chromosome 7 was homozy-
gously affected by somatically acquired rearrangements, one
homolog was lost (27), and the second exhibited the t(7q34 or
q35). One may speculate that the translocation breakpoint
disrupts a gene relevant to the leukemogenic event. Transloca-
tions commonly lead to the activation of proto-oncogenes or to
chimeric fusion genes; however, some translocations have been
shown to be accompanied by submicroscopic deletions and
have led to the identification of a genomic segment likely
containing a novel tumor suppressor.25,26 Based on the physical
map available, the estimated distance between the translocation
breakpoint and the commonly deleted region is approximately 2
to 3 Mb. One possible interpretation of the significance of this
translocation breakpoint is that—by analogy to the proximal
critical region in 7q22-q31—there is heterogeneity of the
translocation and deletion breakpoints.11-13,16 More than one
gene in either critical region of chromosome 7 could be
involved.
Only the gene encoding ras homologue enriched in brain 2
(RHEB) has been mapped to the commonly deleted region.27
The region has not yet been fully sequenced; thus, it is likely
that other unidentified genes localize to this region. None of the
genes that are located in the distal part of 7q and may be
candidates based on their protein function such as NEDD2,
XRCC2, and TIM map to the commonly deleted region or to the
genomic segment containing the translocation breakpoint.28-30
In the present study, we defined a genomic fragment in
chromosome bands 7q35-q36 that is commonly affected in
malignant myeloid disorders. Refinement of the critical region
by the analysis of additional tumor samples together with the
growing data from the human chromosome 7 mapping and
sequencing project will facilitate the identification of the
relevant disease gene(s).
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